Cumberland Pharmaceuticals Inc. · Nashville, TN United States (NASDAQ: CPIX)
| 2525 West End Ave., Ste. 950 | Phone: 615-255-0068 |
| Nashville, TN | Fax: 615-255-0094 |
| 37203 | |
| United States | 
Map This Company |
Cumberland Pharmaceuticals Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Cumberland Pharmaceuticals wants to make your search for the right drugs less cumbersome. The specialty pharmaceutical company focuses on acquiring, developing, and commercializing branded prescription drugs. Targeting the hospital acute care and gastroenterology segments, Cumberland's FDA-approved drugs include Acetadote for the treatment of acetaminophen poisoning; Kristalose, a prescription strength laxative; and Caldolor (neé Amelior), the first injectable dosage form of ibuprofen. The company also has several projects in early-stage development. Acetadote and Kristalose are marketed through Cumberland's own hospital and gastroenterology sales forces. The company went public in a mid-2009 IPO.
Cumberland Pharmaceuticals Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: CPIX Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 131 |
Executives
24 executives listed for Cumberland Pharmaceuticals Inc.'s Nashville, TN location.
| Chairman, CEO, and Principal Financial Officer | A. J. Kazimi | |
|---|---|---|
| SVP Operations | Leo Pavliv | |
| VP and CFO | David Lowrance |